Co-Diagnostics, Inc. - 8-K Filing
Co-Diagnostics, Inc. entered into a private placement agreement on May 19, 2026, raising $3.0 million through the issuance of shares and warrants to institutional and accredited investors. The transaction includes 54,915 common shares, pre-funded warrants for 1,592,532 shares at $0.0001 per share, and common warrants for 3,294,894 shares exercisable at $1.571 per share. Maxim Group LLC served as the exclusive placement agent. (Items: 1.01 Entry Into a Material Definitive Agreement, 3.02 Unregistered Sales of Equity Securities The applicable information related to the Purchase Agreement presented in Item 1, 8.01 Other Events On May 19, 2026, the Company issued a press release announcing the Private Placement, 9.01 Financial Statements and Exhibits)
Tickers: $CODX